Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative in vitro study of teichomycin A2.

V Fainstein, B LeBlanc, G P Bodey

    Antimicrobial Agents and Chemotherapy
    |March 1, 1983
    PubMed
    Summary

    Teichomycin A2 shows strong in vitro activity against various bacteria, comparable to vancomycin. Its effectiveness against gram-positive cocci warrants further clinical investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Design of a Thomson scattering diagnostic for the SMall Aspect Ratio Tokamak (SMART).

    The Review of scientific instruments·2024
    Same author

    Two-dimensional AXUV-based radiated power density diagnostics on NSTX-U.

    The Review of scientific instruments·2014
    Same author

    Chromatin folding: from linear chromosomes to the 4D nucleus.

    Cold Spring Harbor symposia on quantitative biology·2011
    Same author

    Unconstrained oral naming abilities of right-hemisphere damaged individuals: A qualitative and time-course analysis.

    Clinical linguistics & phonetics·2011
    Same author

    Biasing, acquisition, and interpretation of a dense Langmuir probe array in NSTX.

    The Review of scientific instruments·2010
    Same author

    Invited commentary: predicting human pharmaceutical cancer risk.

    Veterinary pathology·2010

    Area of Science:

    • Microbiology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Antibiotic resistance is a growing global health concern.
    • Novel antimicrobial agents are crucial for combating resistant bacterial infections.
    • Teichomycin A2 is a glycopeptide antibiotic with potential therapeutic applications.

    Purpose of the Study:

    • To evaluate the in vitro antimicrobial activity of Teichomycin A2.
    • To compare the efficacy of Teichomycin A2 with existing antibiotics.
    • To assess the potential clinical utility of Teichomycin A2.

    Main Methods:

    • In vitro susceptibility testing of Teichomycin A2 against clinical bacterial isolates.
    • Comparative analysis of Teichomycin A2 activity against vancomycin and other antibiotics.
    • Microbiological assays to determine minimum inhibitory concentrations (MICs).

    Main Results:

    • Teichomycin A2 demonstrated significant in vitro activity against all tested organisms.
    • Its antimicrobial activity was comparable to vancomycin.
    • Teichomycin A2 exhibited superior efficacy against gram-positive cocci compared to several other antibiotics.

    Conclusions:

    • Teichomycin A2 possesses potent in vitro antimicrobial properties.
    • The compound shows promise as a therapeutic option, particularly against gram-positive cocci.
    • Further clinical evaluation of Teichomycin A2 is recommended based on its in vitro performance.

    Related Experiment Videos